Skip to content
Abierto

Sources sought

SIR Y90 Microspheres

W81K0427QA001

Department of the Army, W40M Mrco East. Irradiation Apparatus Manufacturing.

Response deadline

May 27, 2026 at 1:00 PM EDT

Closed 113 days ago. Posted May 15, 2026. Scheduled to archive May 27, 2026.

Description

As published on SAM.gov.

This is a Request for Information (RFI) – Sources Sought Notice Only. This notice is issued solely for information and planning purposes only. The US Government will not pay for any information or administrative costs incurred in response to this notice. Submittals will not be returned to the responder; not responding to this notice does not preclude participation in any further RFQ; IFB or RFP if issued.

Health Readiness Contracting Office -(HRCO), Womack Army Medical Center (WAMC), Fort Bragg, NC 28310, intends to solicit, negotiate, and award a sole sourced contract to Sirtex Medical Inc. 300 Unicorn Park Drive Woburn, MA 01801, United States. Sirtex Medical Inc will provide SIR-Spheres® Y-90 resin microspheres and other materials used in conjunction with the microspheres.

SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Additionally, there are no other companies or firms that sells or distribute such items. The solicitation number is W91YTZ27QA0011, and the resulting award will be made on DD Form 1449 (Order for Commercial Items). This requirement is for commercial supply for the Department of Nuclear Medicine.

The NAICS for this requirement is 334517- Irradiation Apparatus Manufacturing, and Product Service Code (PSC)- Q527 Medical- Nuclear Medicine. The point of contact for this requirement is Frank Fogg frank.a.fogg.civ@health.mil. The Contracting Officer is Amush Collins at anush.m.collins.civ@army.mil. Your email response shall provide the following:

Can you provide supply the following supply: Sirtex Medical Inc will provide SIR-Spheres® Y-90 resin microspheres and other materials used in conjunction with the microspheres. SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Additionally, there are no other companies or firms that sells or distribute such items.

If your company can offer this supply item please respond via e-mail to the POC with: Name of Company Point of contact Phone number Email address Identify Your Small Business Socio-Economic Group DUNS number and CAGE Code No telephonic inquiries will be responded to

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 15, 2026

    Sources sought

    Due May 27, 2026 at 1:00 PM EDT. SAM.gov, notice acdbaccb4bfe41c7adb9595c01d44f81

Points of contact